Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor

OBJECTIVES : To investigate differences in response to tumor necrosis factor inhibitor treatment (TNFi) in seropositive (rheumatoid factor positive; RF+) versus seronegative (RF-) patients with established RA as measured by the Health Assessment Questionnaire Disability Index (HAQ-DI) and pain. METH...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Aberumand, Babak, Barra, Lillian, Cao, Yang, Riche, Nicole Le, Thompson, Andrew E, Rohekar, Gina, Rohekar, Sherry, Bonner, Ashley, Pope, Janet E
Format: Artigo
Jezik:Inglês
Izdano: Bentham Open 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209495/
https://ncbi.nlm.nih.gov/pubmed/25352925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312901408010073
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items